
-
2000 March 28
Company Description
Epirus Biopharmaceuticals develops biosimilar monoclonal antibodies and therapeutic proteins for emerging markets.
EPIRUS is focusing on the central development of a broad pipeline of biosimilar monoclonal antibodies and therapeutic proteins, optimized for use within the SCALE disposable manufacturing system, and designed to be deployed in an 'In Market, For Market' manufacturing configuration.
-
Manufacturer:
Science and Engineering -
Formed:
March 28, 2000 -
Company Website:
-
Company E-mail:
-
Company Address:
699 Boylston Street, 11th FloorBoston, MAUnited States -
CEO:
- Michael Wyand
-
We recognize our sponsors starting at $1 per entry.
Learn more at https://www.ithistory.org/benefits